NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 62 filers reported holding NEOGENOMICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $162,000 | -77.6% | 18,850 | -79.0% | 0.04% | -67.7% |
| Q2 2016 | $723,000 | +803.8% | 89,892 | +788.8% | 0.13% | +1377.8% |
| Q4 2015 | $80,000 | -89.0% | 10,114 | -92.5% | 0.01% | -87.3% |
| Q2 2015 | $726,000 | -60.3% | 134,225 | -65.7% | 0.07% | -60.3% |
| Q1 2015 | $1,828,000 | -19.2% | 391,338 | -27.8% | 0.18% | -17.1% |
| Q4 2014 | $2,261,000 | -49.8% | 542,231 | -37.3% | 0.22% | -44.6% |
| Q3 2014 | $4,507,000 | +739.3% | 865,092 | +434.4% | 0.39% | +828.6% |
| Q2 2014 | $537,000 | -4.8% | 161,893 | -0.3% | 0.04% | +13.5% |
| Q1 2014 | $564,000 | +40.0% | 162,411 | +45.9% | 0.04% | +94.7% |
| Q4 2013 | $403,000 | +1051.4% | 111,302 | +848.5% | 0.02% | +850.0% |
| Q3 2013 | $35,000 | – | 11,734 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
| PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
| Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
| First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
| Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
| Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
| Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
| EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
| Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |